Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
182 Cards in this Set
- Front
- Back
____ refers to a "new growth" of abnormal tissue (usually derived from a single cell precursor) that serves no physiologic function and, for the most part, is independent of normal restraints on orderly growth.
|
neoplasia
|
|
In neoplasia, cells normally dont replicate unless they are stimulated by ___ released in response to physiologic, pathologic, or reparative demands.
|
endogenous or exogenous growth factors
|
|
T/F Neoplastic cells have the ability to replicate in the absence of growth factors or they may replicate excessively in response to normal stimuli.
|
True
|
|
Inherited genetic influence play a direct role in the development of certain neoplasms (retinoblastoma, neurofibromatosis, multiple endocrine neoplasia syndrome), epidemiologic evidence suggest that 75-90% of human neoplasia is due, in part, to what?
|
environmental factors
|
|
Tissues most directly exposed to the environment, such as ___, ___, and ___, tend to show higher rates of neoplastic transformation.
|
skin, respiratory tract, gastrointestinal tract
|
|
Neoplastic transformation is a (quick/progressive) process involving (one/multiple) steps and in the majority of cases involves _____.
|
progressive
multiple somatic mutations of cellular DNA |
|
Neoplasia is a ____ disease in that the fundamental cellular changes occur at the level of ___ but these changes are induced by ___ factors.
|
genetic
DNA environmental |
|
What are denoted by the suffix "-oma" which usually indicates a neoplastic process but occasionally may be applied to a non-neoplastic mass (hematoma, granuloma, xanthoma, etc).
|
tumors
|
|
An unmodified suffix generally denotes a ___ neoplasm while for malignant neoplasms the suffix is modified to either ____ (referring to epithelial malignancies) or ____ (referring to mesenchymal/connective tissue malignancies.
|
carcinoma
sarcoma |
|
malignant neoplasm of melanocytes
|
melanoma
|
|
malignant neoplasm of lymphoid tissue
|
lymphoma
|
|
malignant neoplasms of supporting tissue of the CNS
|
glioma
|
|
malignant tumors arising from early, partially differentiated embryonal tissue
|
blastoma
|
|
neoplasm which contains cells from more than one embryonic germ cell layer and may be benign or malignant
|
teratoma
|
|
a non-neoplastic "tumor" that represents abnormal overgrowth or differentiation of cells native to the tissue of origin
|
hamartoma
|
|
presence of normal tissue in an abnormal location
|
choristoma (also termed ectopic or heterotopic tissue)
|
|
What is the prefix for glandular epithelium?
|
adeno
|
|
What is the prefix for:
-squamous epi -transitional epi -fibrous CT |
-squamous
-transitional -fibro |
|
What is the prefix for smooth muscle?
|
leiomyo
|
|
What is the prefix for skeletal muscle?
|
rhabdomyo
|
|
What is the prefix for adipose tissue?
|
lipo
|
|
What is the prefix for:
-cartilage -bone -blood vessel -lymphatic vessel |
chondro
osteo hemangio lymphangio |
|
What prefix indicates hard due to excessive production of tumor stroma?
|
scirrhous
|
|
What prefix indicates soft, resembling marrow, due to scant production of tumor stroma?
|
medullary
|
|
What prefix indicates gelatinous, mucinous?
|
colloid
|
|
What prefix indicates fluid or gas filled spaces?
|
cystic
|
|
What prefix indicates the growth pattern of forming follicles?
|
follicular
|
|
What prefix indicates the growth pattern of forming small cystic spaces?
|
cyst
|
|
What prefix indicates the growth pattern of forming "nipple-like" projections?
|
papillary
|
|
What prefix indicates the growth pattern of forming shaggy, "finger-like" projections?
|
villous
|
|
What prefix indicates a growth pattern of pierced by small holes?
|
cribriform
|
|
The distinction bw benign and malignant tumors is based on what?
|
their microscopic appearance and clinical behavior
|
|
What do the differences bw benign and malignant tumors generally relate to?
|
-cellular morphology
-cellular differentiation -rate of growth -mode of growth -metastasis |
|
___ cells resemble the normal morphology of the cell of origin while ___ cells are characterized by cellular and nuclear pleomorphism (due to alterations in the cell cytoskeleton); increased nuclear/cytoplasmic ratio; increased nuclear chromatin which is frequently "clumped" along an irregular nuclear membrane; large nucleoli; bizarre mitoses; loss of cellular orientation; and to some degree, loss of normal functional capacity.
|
benign neoplastic
malignant neoplastic |
|
Cells of benign neoplasms (are/ are not) well differentiated (all cells closely resemble the cell of origin), have a (normal/abnormal) number of chromosomes, and (retain/ do not retain) functional capabilities.
|
-are
-normal -retain |
|
Which cells show abnormalities in the number or structure of chromosomes and, within the same tumor, may vary from complete lack of differentiation (___) to well differentiated?
|
malignant
anaplasia () |
|
What tends to parallel the degree of differentiation of neoplastic cells?
|
rate of growth
|
|
What is the rate of growth for benign neoplasias?
|
slow growth or may, on occasion, spontaneously regress
|
|
What is the rate of growth for malignant neoplasias?
|
grow more rapidly and rarely cease growth or regress
|
|
(Benign/malignant) neoplasms grow by expansion and tend to compress the surrounding tissue into a "capsule" that separates the tumor from normal tissue.
|
benign
|
|
(benign/malignant) tumors grow by infiltration and invasion of the surrounding tissue and are not confined by a capsule.
|
malignant
|
|
What refers to the spread of a neoplasm to points that are not contiguous with the primary lesion?
|
metastasis
|
|
____ tumors do NOT metastasize, but all ____ neoplasms have metastatic potential ?
|
benign
malignant |
|
What are the different ways metastases can occur?
|
-lymphatic dissemination
-hematogenous dissemination -transcoelomic seeding -traumatic seeding |
|
What is the most common route of metastasis (especially for epithelial neoplasms (carcinomas))?
|
lymphatic dissemination
|
|
____ refers to the most common route of metastasis and follows the natural lymphatic drainage of the site of malignancy; regional lymph nodes may be enlarged due to metastatic tumor or to immune reaction to the presence of tumor products.
|
lymphatic dissemination
|
|
Which metastasis route is characteristic of connective tissue neoplasms (sarcomas)? Carcinomas are also spread by this route since there are vascular-lymphatic anastomoses. Invasion and metastases are more likely to occur via the ____ system due to its thin walled structure.
|
hematogenous dissemination
venous |
|
Metastasis may occur via ___ with malignancies that involve coelomic (peritoneal, pleural) surfaces.
|
transcoelomic seeding
|
|
Metastasis may occur via ___ when excessive manipulation or cutting into malignant tumors may detach and carry small portions of the tumor to other sites.
|
traumatic seeding
|
|
(benign/malignant) neoplasms may cause significant morbidity or kill patients by virtue of their anatomic position (pituitary adenoma, craniopharyngioma, meningioma, etc). Even small tumors may cause death by interfereing w/ vital functions (brainstem, conduction of the heart).
|
both
|
|
Local affects of neoplasia:
-(benign/malignant/both) neoplasms may cause compression of surrounding structures. -(benign/malignant/both) are more prone to infarction, necrosis, hemorrhage, ulceration, and infection -(benign/malignant/both) stimulate excessive production of connective tissue (desmoplasia) |
-both
-malignant -malignant |
|
Systemic effects of neoplasia:
-Some tumors (benign or malignant) may produce a hormone or hormone-like substances that can have systemic effects known as ____ (ex.____). Other effects may relate to hypercoagulabilty, thrombocytopenia, migratory thrombophlebitis, cachexia, sepsis, electrolyte imbalances, etc. |
paraneoplastic syndromes (hypercalcemia, Cushing's syndrome, Syndrome of Inappropriate ADH Secretion, polycythemia, etc)
|
|
What are considered cariogenic agents?
|
chemicals
radiation viruses |
|
The cariogenicity of various chemcial agents appears to be ___ dependent so that multiple fractional doses over time have the same transforming potential as a comparable one-time dose.
|
dose
|
|
Although some chemical compounds act on cells directly, most chemical substances require ____ for conversion into ultimate carcinogens.
|
metabolic activation
|
|
Most of the known carcinogens are metabolized by ___ in the ___.
|
cytochrome P-450- dependent mono-oxygenases in the liver
|
|
What factors can modify the carcinogenic effect of a chemical by affecting its metabolism?
|
age, sex, nutritional status, etc
|
|
Transformation of a normal cell to a neoplastic cell with chemical carcinogens occurs in what stages?
|
Initiation
Promotion Conversion Progression |
|
Which stage in the chemical transformation of a normal cell to a neoplastic cell can produce permanent changes in the genetic make-up of a cell by reacting w/ DNA to cause strand breaks, to alter methylation, or to hinder DNA repair. The DNA changes however must not be so severe as to prevent the cell from being able to replicate. They DO NOT stimulate cell division, and do not have growth autonomy nor do they have unique, readily identifiable genotype or phenotype markers.
|
chemical initiators
|
|
Which stage in the chemical transformation of a normal cell to a neoplastic cell can induce neoplastic transformation in a previously initiated cell but cannot cause neoplastic transformation in and of themselves in a non-initiated cell. Instead of altering the DNA, their action seems to induce clonal proliferation of initiated cells by altering the regulation of mitosis and the differentiation and maturation pathways.
|
chemical promoters
|
|
Ultimately in the chemical transformation of a normal cell to a neoplastic cell the cells become ___ and are no longer dependent on the promoters for proliferation.
|
converted
|
|
During the chemical transformation of a normal cell to a neoplastic cell, once the neoplastic cells become autonomous, continued genetic mutation confers new attributes to ___ of the neoplastic cells.
|
subclones
|
|
Ionizing radiation can produce ___ that mediate cellular damage by breaking or altering chemical bonds.
|
free radicals
|
|
What can inactivate enzymes, alter proteins, and cause chromosomal breakage, translocations, and point mutations. It can also inhibit cell-mediated immunity and therefore tumor surveillance.
|
Ionizing radiation
|
|
The ability of ionizing radiation to induce neoplastic transformation correlates best with its ability to what?
|
induce genetic mutation within the cell
|
|
What viruses have been found to be associated w/ human neoplasia (carcinoma of the uterine cervix, hepatocellular carcinoma, Burkitt's lymphoma)?
|
both DNA and RNA viruses
|
|
Through what processes are viruses able to directly rearrange the structure or alter the expression of the host cell genome?
|
transduction and insertional mutagenesis
|
|
T/F In order for a cell to be transformed to a neoplastic cell via a virus, the host cell must survive the viral infection and be able to reproduce.
|
true
|
|
In tissue culture, neoplastic cells appear to be freed from normal regulatory controls and have an (increased/decreased) rate of stem cell renewal and their growth (is/ is no longer) inhibited by the presence of neighboring cells.
|
increased
is no longer (loss of contact inhibition) |
|
Do malignant cells require attachment to a hard surface to proliferate?
|
No, they have anchorage independent growth and are less cohesive (loss of surface cellular adhesion molecules)
|
|
Malignant cells require (fewer/more) exogenous growth factors and in general are ____.
|
fewer (if any)
immortal (cell lines can be kept alive indefinitely |
|
Malignant cells can develop ___ properties (probably related to cytoskeletal changes or production of enzymes unduced by oncogene activation) and ______ potential and when injected into other animals, these cells will prodce ___ (transplantability).
|
-invasive
-metastatic -neoplasms |
|
What are the specific genetic sequences called that are capable of transforming normal cells into neoplastic cells and were first identified in DNA viruses and RNA tumor viruses (retroviruses) that were known to produce malignancies in animals?
|
viral oncogenes (v-onc)
|
|
What genetic sequences were found to not be of true viral origin but instead was found to be very similar to genetic sequences found in normal cellular DNA which implies that these segments at some point in the past had been incorporated into the ancestral viral genome while the virus was replicating within an infected host and had been maintained via viral replication?
|
viral oncogenes
|
|
What is it called when a normal cell has genetic information that could potentially transform that cell into a neoplastic cell under the appropriate conditions?
|
proto-oncogenes
|
|
Genetic material from a neoplastic cell can transform a normal cell into a neoplastic cell. The genetic sequences capable of inducing this transformation are termed what?
|
cellular oncogenes (c-onc)
|
|
Cellular oncogenes are similar in sequence to normal proto-oncogene sequences and may have arisen through ____ of the proto-oncogenes. Proto-oncogenes, therefore, have the potential of being converted (through mutations, retroviral transduction, increased expression, etc) to oncogenes that can promote what?
|
-simple somatic mutation
-excessive or inappropriate cell proliferation |
|
Like all other genes, each proto-oncogene is composed of a ____ and ____ region and changes in either region could produce an active oncogene.
|
regulatory and a structural region
|
|
What kind of mutation can lead to synthesis of a protein that has aberrant structure and function?
|
structural
|
|
How do structural mutations occur?
|
through point mutations, insertions/deletions, or translocations
|
|
What causes alteration of a single base pair which may alter the protein product of a proto-oncogene?
|
point mutation
|
|
What occurs randomly throughout proto-oncogenes, but only those occurring at certain critical "hot spots" produce oncogenic activation?
|
point mutations
|
|
Point mutations are best exemplified by what oncogenes?
|
ras
|
|
If these occur in the structural region, they may result in altering the protein product of a proto-oncogene.
|
Insertions/deletions
|
|
What can affect the biochemical functions of proto-oncogenes by fusion with new genetic sequences?
|
translocations
|
|
What results from a translocation that encodes a protein different from the normal protein?
|
the c-abl oncogene (Philadelphia chromosome) in chronic myelogenous leukemia; t(9;22)
|
|
With ___ changes, mutations affect the amount of protein product rather than the structure.
|
regulatory
|
|
What do regulatory changes occur through?
|
translocations or gene amplifications
|
|
Proto-oncogenes may become activated either because they are placed next to strong promoter/enhancer sequences or because ____ removes them from the influence of normal regulatory control sequences. ex: the ___ oncogene in Burkitt's lymphoma
|
translocation
c-myc |
|
What produces many copies of an oncogene and therefore increases the amount of protein synthesis?
|
gene amplification
|
|
In karyotype studies, gene amplification can be observed as___ if they stay associated with the chromosome or as ___ if they break loose and replicate as extrachromosomal material.
|
-homogeneously staining regions (HSR)
-double minutes (DM) |
|
The ___ oncogenes are amplified in neuroblastomas and small cell carcinomas of the lung; ___ is amplified in breast cancers; and ___ is amplified in glioblastoma multiforme
|
-myc
-HER2/neu -erbB |
|
Like the protein products of normal proto-oncogenes, the protein products of oncogenes are involved in the regulatory pathways that control ___ and ___ and are capable of transforming normal cells into neoplastic ones.
|
cellular division and differentiation
|
|
What are the growth factor proteins?
|
sis, int-2
|
|
What are the growth factor receptor proteins?
|
erbB, fms
|
|
What are the GTP-Binding proteins?
|
ras family
|
|
What are the non-receptor tyrosine kinases?
|
src, abl
|
|
What are the DNA-binding proteins?
|
myc family
|
|
What are the transcription regulators?
|
fos, jun
|
|
Which oncogenes may code for large amounts of growth factors to which the cell can respond (autocrine stimulation) or they may impart growth autonomy by deregulating genes that encode growth factors?
|
c-sis
|
|
What oncogene may encode proteins that enter the nucleus and directly stimulate cellular growth?
|
c-sis
|
|
Which family of oncogenes appear to influence signal transduction?
|
ras
|
|
Which family of oncogenes modifies the cytoskeletal protein, vinculin, which anchors actin filaments to the cell membrane and also allows expression of otherwise tightly regulated growth factor genes?
|
c-src
|
|
Which family of oncogenes seems to make cells more responsive to growth factors controlling cell proliferation and appears to confer immortality to the cell line?
|
myc family
|
|
What are tumor suppressor genes called?
|
anti-oncogenes
|
|
The expression of genes that serve to protect the cell from the events leading to neoplastic transformation are referred to as what?
|
tumor suppressor genes
|
|
The protein products of ___ modulate the activity of proto-oncogenes, oncogenes, or their protein products.
|
tumor suppressor genes
|
|
What could arise in the absence of tumor suppressor genes?
|
neoplasia
|
|
What tumor suppressor gene becomes much more active after DNA damage?
|
p53 tumor suppressor gene on the short arm of chromosome 17
|
|
What does the p53 tumor suppressor gene code for?
|
a protein that binds to damaged DNA and inhibits cell mitosis until damaged DNA can be repaired by the DNA repair genes. If the damage is too sever to be repaired, the cell will undergo apoptosis.
|
|
What happens in the absence of a functional p53 tumor suppressor gene?
|
the cell may continue to reproduce incorporating the DNA mutation into the genome of the cell line.
|
|
Mutations and inactivation of the p53 gene are seen in numerous human malignancies such as what?
|
astrocytoma of the brain and carcinoma of the colon
|
|
Defects in ___ may predispose to malignant transformation and may have been associated with various cancer syndromes such as xeroderma pigmentosum.
|
DNA repair genes
|
|
___ mutations that activate an oncogene allele or inactivate a tumor suppressor gene allele may be inherited and could be a predisposing risk factor for the development of neoplasia since that individual has inherited only one, rather than two, normal copies of the gene allele.
|
heterozygous
|
|
Oncogene activation (or tumor suppressor gene inactivation) of the corresponding locus (loss of heterozygosity) by somatic mutation may result in what?
|
overt neoplastic development
|
|
Loss of heterozygosity has been identified on the short arm of chromosome 3 in what carcinomas?
|
renal cell carcinomas and small cell carcinomas of the lung
|
|
Loss of heterozygosity has been identified on the short arm of chromosome 11 in what?
|
Wilms' tumor of the kidney
|
|
Loss of heterozygosity has been identified on the long arm of chromosome 13 in what carcinomas?
|
retinoblastoma and ductal carcinoma of the breast
|
|
When is a mutated allele present in all cells giving a greater tendency to develop multiple tumors?
|
when the mutated allele is inherited
|
|
Many of the ___ neoplasia syndromes appear to be the result of inheriting at least one mutated gene allele.
|
autosomal dominant (ex. multiple endocrine neoplasia syndromes, familial polyposis coli, Von Recklingshausen disease)
|
|
If somatic mutation and activation of an oncogene allele (or inactivation of a tumor suppressor gene allele) occurs, the chances of altering both alleles in a single cell are much less than the chance of altering one allele. When this does occur, however, the subsequent neoplasia is much more likely to be ____ than multiple as seen with the _____ neoplasia syndromes.
|
-solitary
-inherited |
|
T/F A single oncogene can transform normal cells into neoplastic cells?
|
False- no single oncogene can transform normal cells into neoplastic cells. More than one oncogene may be involved, with each supplying some of the function required to convert the cell from normal to neoplastic
|
|
What is a distinguishing feature of neoplasia that may be the result of genetic alterations (oncogene activation, tumor suppressor inactivation) that direct the cell to replicate rather than to continue to differentiate?
|
the propensity of tumor cells to reproduce
|
|
Evidence suggest that most tumors are of what origin?
|
monoclonal (a single cell from normal or pre-neoplastic tissue becomes neoplastic at a specific level of differentiation and the clonal derivatives of that cell produces the neoplasm
|
|
In most tumors there appears to be an (increase/decrease) in the proportion of stem cells undergoing replication and a corresponding (increase/decrease) in the proportion progressing to full end-stage maturation.
|
increase
decrease |
|
What refers to the proportion of cells within a tumor population that are in the proliferating pool?
|
growth fraction (GF)
|
|
The rate of tumor growth depends upon the ___ and the degree of imbalance between cell production and cell loss.
|
growth fraction
|
|
Most tumors have a (high/low) GF and proliferation (greatly/slightly) exceeds cell loss.
|
low
slightly |
|
The growth fraction of a tumor has a profound effect on its susceptibility to what?
|
chemotherapy
|
|
What do cancer drugs primarily act on?
|
dividing cells (therefore, tumors w/ a high growth fraction are most vulnerable)
|
|
(Slow/Fast) growing tumors which have a high proportion of cells outside the cell cycle respond less favorably to chemotherapy and harbor cells which can potentially reenter the cycle at a later time.
|
slow
|
|
Tumor growth is dependent upon ___ without which neoplastic growth will stop at approximately 1mm diameter due to the limited diffusion capacity of oxygen and solutes.
|
vascularization
|
|
What do angiogenic factors promote and control?
|
the neovascularization of the expanding cell mass (neovasculature tends to be loose abnormal due to loose endothelial junctions)
|
|
What are considered angiogenic factors?
|
fibrinogen and various substances produced by the tumor cells (angiogenin, fibroblast growth factor)
|
|
What is not uncommon in tumors and, in the case of malignant tumors, may even help assist the tumor cells to spread to other sites?
|
hemorrhage
|
|
What in the tumor environment can significantly impair the biologic effect of radiation therapy and some forms of chemotherapy which are oxygen dependent?
|
hypoxia
|
|
What can influence the growth rate of hormonally responsive tissues?
|
circulating hormones
|
|
A greater degree of angiogenesis within a tumor is correlated with a (less/more) aggressive behavior and (poorer/better) prognosis.
|
more
poorer |
|
As tumor size increases, the time it takes for a tumor to double in volume (increases/decreases) due to diminished blood supply, competition for metabolites, and other factors that lead to a decrease in the growth fraction and an increase in cell loss.
|
increases (growth rate slows down)
|
|
As tumors enlarge, an (increasing/decreasing) proportion of tumor cells drop out of the mitotic cycle either because of necrosis or by entering into prolonged G1 periods or the G0 phase of the cell cycle.
|
increasing
|
|
T/F Even though the doubling time slows down as tumors enlarge, by the time a solid tumor is clinically detected it has already completed a major portion of its life cycle.
|
True
|
|
T/F The later a tumor is identified, the greater the chance of successful radiation and/or chemotherapy.
|
False- the earlier a tumor is identified
|
|
Although tumors probably arise monoclonally, by the time they have reached clinical detection, the cell population is ____ in respect to morphologic appearance, karyotype, degree of differentiation, invasiveness, metastatic capabilities, etc implying that tumors can undergo ____ as they develop, probably related to DNA instability and the high rate of random mutation in neoplastic cells.
|
-heterogenous
-clonal evolution |
|
____ cell are more likely to have characteristics that enable them to spread (increased motility, decreased adhesiveness, decreased anchorage dependence, etc).
|
dedifferentiated
|
|
_____, like the progression of pre-neoplasia to neoplasia, appears to involve a sequence of oncogene activations that, over time, leads to more highly malignant cells (those that have a survival advantage due to their growth rate, invasiveness, drug resistance, etc)
|
clonal evolution
|
|
By the time most malignant neoplasms have become clinically detectable, it is likely that they have evolved several subclones with ___ potential which implies that the earlier a cancer can be identified, the less likely it is that more aggressive subclones have developed.
|
metastatic
|
|
What type of cells have the ability to invade surrounding tissue and ultimately spread to distant sites?
|
malignant cells
|
|
What cells within a tumor have a high invasive and/or metastatic potential with a high mutation rate?
|
cell clones
|
|
Evidence suggests that ___ activation is involved in conferring metastatic potential on tumor cells by enabling the cell to attach to, degrade, and penetrate basement membranes and interstitial connective tissue.
|
oncogene
|
|
Malignant epithelial cells are (less/more) adherent to one another and become (less/more) "mobile" due to (loss/gain) of normal cell adhesion molecules.
|
-less
-more -loss (or inactivation) |
|
What do malignant epithelial cells bind to that are embedded in basement membranes and the extracellular matrix?
|
structural glycoproteins such as laminin and fibronectins
|
|
Since ___ adheres tightly to the type IV collagen of the basement membrane, neoplastic cells may evolve mechanisms to secrete ___ or alternatively, to produce tumor membrane receptors that binds native ___.
|
laminin
|
|
Once secured to the basement membrane, what do tumor cells secrete to dissolve the basement membrane?
|
proteases such as type IV collagenase
|
|
Once the tumor cells secrete proteases to dissolve the basement membrane, they are then free to attach to ___ with additional release of proteases.
|
stromal fibronectin
|
|
The ability of tumor cells to digest ground substance (collagen, glycoproteins, proteoglycans, and elastin) by the production of proteases and metalloproteinases is correlated with ____ potential.
|
invasive
|
|
It is likely that cancer cells interact with host fibroblasts and other mesenchymal cells and stimulate them to secrete what?
|
additional collagenases
|
|
Tumor derived growth factors as well as breakdown products of the extracellular matrix have angiogenic adn tumor chemotactic activities which promote what?
|
neovascularization and recruitment of additional tumor cells
|
|
What makes it relatively easy for tumor cells to gain access to circulation?
|
loose endothelial junctions of the new vessels made via neovascularization
|
|
Due to their lack of a basement membrane, what vessels are easily invaded by tumor cells?
|
lymphatic channels (walls of venules and veins are easily invaded as well)
|
|
T/F Hemmorhage and necrosis also promote the release of tumor cells into the circulation.
|
True
|
|
Once in circulation, what are tumor cells vulnerable to?
|
-hemodynamic factors that cause cell trauma
-to immunologic recognition and attack (particulary by NK cells) -to other adverse conditions |
|
How many tumor cells released into the bloodstream will ultimately metastasize?
|
fewer than 1 in 1000
|
|
In circulation, what do tumor cells tend to do?
|
aggregate into clumps
|
|
T/F Clumps of five to ten tumor cells appear less effective in producing metastases than either single cells or larger clumps.
|
F- more effective
|
|
Some clumps of tumor cells adhere to platelets or produce procoagulants which form "shields" of precipitated ___ to ward off immunologic recognition. These procoagulants may partly explain some of the hypercoagulable states seen in patients w/ desseminated cancer.
|
fibrin
|
|
What is the regional spread of tumors primarily influenced by?
|
the anatomy of regional lymphatics
|
|
Does metastases from malignant tumors display preferences for some tissue sites over others?
|
yes, a variety of malignant tumors do
|
|
T/F Metatastic deposits, like primary tumors, are clonal in origin and the survival and growth of the metatastic lesion generally depends on the same factors that enable growth of the primary lesion.
|
True
|
|
What type of antigen refers to antigens that are found on neoplastic cells and not on normal cells?
|
tumor specific antigens
|
|
In animals, each individual tumor induced by a given chemical carcinogen frequently (carries its own unique tumor antigen/share a common antigen) while all tumors produced by a given virus (carries its own unique tumor antigen/share a common antigen).
|
-carries its own unique tumor antigen
-share a common antigen |
|
___ antigens can activate host immunologic destruction of cancer cells in animals but whether this occurs in humans to any significant extent is not known.
|
tumor-specific antigens
|
|
What type of antigens are found in normal cells but which are present in higher concentration in tumor cells?
|
tumor associated antigens
|
|
What type of tumor associated antigens are expressed at certain stages of a cell's maturation?
|
differentiation antigens (beta HCG)
|
|
What type of tumor associated antigens are expressed during embryonic development but normally repressed during adult life?
|
oncofetal antigens (CEA, AFP)
|
|
What refers to the microscopic pathologic determination of tumor aggressiveness based on the degree of differentiation of the neoplastic cells and the number of mitoses as an estimate of the rate of growth?
|
Grading
|
|
Most tumors are graded from I (low/high grade; undifferentiated/well differentiated) through IV (low/high grade; undifferentiated/well differentiated)?
|
-low grade; well differentiated
-high grade; undifferentiated |
|
Many malignant neoplasms progress to a (lower/higher)grade over time as (less differentiated/undifferentiated) clones of cells become dominant.
|
-higher
-less differentiated |
|
Is a lower or higher grade a better prognosis?
|
lower
|
|
What refers to the clinical and pathologic determination of tumor aggressiveness based on the size of the neoplasm, the presence or absence of regional lymph node involvement, and the presence or absence of distant metastases?
|
Staging
|
|
Staging is the basis of what?
|
the TNM (tumor size, node involvement, metastasis) staging system
|
|
How are tumors staged?
|
numerically from 0 (localized tumor) through IV (distant metastases), and some are staged alphabetically from A (localized tumor) to D (metastatic tumor)
|
|
The (smaller/larger) the tumor and the more localized it is, the (better/worse) the prognosis.
|
-smaller
-better |